FDA Drug Safety Podcasts podcast

Player FM - Internet Radio Done Right

11 subscribers

تمت الإضافة منذ قبل four أعوام

المحتوى المقدم من U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.

Motivational Speeches, Inspiration & Real Talk with Reginald D (Motivational Speeches/Inspirational Stories)

1
Tariffs For Your Life: Breaking Free From Emotional Debt, Spiritual Burnout & Hidden Trauma (Motivational Speech) 12:46

منذ 9 weeks12:46

التشغيل لاحقا

قوائم

إعجاب

احب

12:46

What if the stress, burnout, and emotional exhaustion you’re feeling isn’t just life — but an invisible fee you’ve been paying for years? In this raw and revealing motivational episode, Reginald D dives deep into the hidden emotional, spiritual, and mental tariffs that silently drain our joy, faith, and purpose. From trauma-induced beliefs to generational pain and toxic relationship cycles, Reginald D unpacks how we’ve been taxed by fear, doubt, shame, rejection — and how to cancel those spiritual fees once and for all. If you’ve ever felt stuck, unworthy, or spiritually bankrupt, this is your wake-up call to walk in the freedom Jesus already paid for . Let's declare your independence from emotional debt and build a life of healing, faith, and abundance. In today’s world, many are depleted and emotionally overwhelmed — not because they’re weak, but because they’re unknowingly paying hidden “tariffs” on their self-worth, identity, and peace. This episode tackles those unseen costs and empowers you to cancel emotional debts passed down from childhood, relationships, or trauma — replacing them with purpose, healing, and truth. If you’ve been overthinking, over giving, or overworking to feel “enough,” you’ll discover how to stop financing your past and finally live free. 3 Key Benefits You’ll Walk Away With: A renewed understanding of your identity in Christ and how to stop letting pain define you Practical insights to identify and cancel emotional and spiritual fees you never agreed to Encouragement to set boundaries, rewrite your internal beliefs, and step boldly into your purpose Press play now and cancel the emotional fees you’ve been paying too long — freedom is your new currency. Send us a text Support the show For daily motivation and inspiration, subscribe and follow Real Talk With Reginald D on social media: Instagram: realtalkwithreginaldd TikTok: @realtalkregd Youtube: @realtalkwithreginald Facebook: realtalkwithreginaldd Twitter Real Talk With Reginald D (@realtalkRegD) / Twitter Website: Real Talk With Reginald D https://www.realtalkwithreginaldd.com Real Talk With Reginald D - Merchandis e…

FDA Drug Safety Podcasts

منزل السلاسل•Feed

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on January 02, 2025 18:56 (5M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts

63 حلقات

#Science #Fitness #Biology #Medicine #Government #Center For Drug Evaluation #Drug Administration #U.S. Food

FDA Drug Safety Podcasts

11 subscribers

updated منذ عام واحد

منزل السلاسل•Feed

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on January 02, 2025 18:56 (5M ago)

63 حلقات

#Science #Fitness #Biology #Medicine #Government #Center For Drug Evaluation #Drug Administration #U.S. Food

كل الحلقات

1
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis 5:00

منذ 22 weeks5:00

5:00

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis

1
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause 3:30

منذ 37 weeks3:30

3:30

Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause.

1
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab) 4:00

منذ 1 year4:00

4:00

Listen to FDA Drug Safety Podcast titled, FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab).

1
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity 3:30

منذ 1 year3:30

3:30

Listen to FDA Drug Safety Podcast, FDA's preliminary evaluation has not found evidence that use of GLP-1 RAs causes suicidal thoughts/actions.

1
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan) 5:05

منذ 1 year5:05

5:05

Listen to an audio podcast of the November 28, 2023, FDA Drug Safety Communication, FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan).

1
FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions 5:30

منذ 2 years5:30

5:30

Listen to an audio podcast of the May 11, 2023, FDA Drug Safety Communication on warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

1
FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use 7:30

منذ 2 years7:30

7:30

Listen to an audio podcast of the April 13, 2023, FDA Drug Safety Communication, FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use.

1
FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab) 4:00

منذ 2 years4:00

4:00

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)

1
FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) 4:00

منذ 3 years4:00

4:00

Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a clinical trial show a possible increased risk of death with Copiktra (active ingredient duvelisib) compared to another medicine to treat leukemia and lymphoma.

1
FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns 2:00

منذ 3 years2:00

2:00

Listen to an audio podcast of the 6/1/22 for Ukoniq . FDA withdrew its approval for the cancer medicine Ukoniq (active ingredient umbralisib) due to safety concerns. Ukoniq was approved to treat two specific types of lymphoma: marginal zone lymphoma (MZL) and follicular lymphoma (FL)

1
FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging 4:30

منذ 3 years4:30

4:30

Listen to an audio podcast of the March 30, 2022 FDA Drug Safety Communication Iodinated Contrast Media

1
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) 3:30

منذ 3 years3:30

3:30

Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses.

1
FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain 5:59

منذ 3 years5:59

5:59

Listen to an audio podcast of the January 12, 2022, FDA Drug Safety Communication warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth.

1
FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury 4:00

منذ 4 years4:00

4:00

“Listen to FDA Drug Podcast, FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury

1
FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions 4:00

منذ 4 years4:00

4:00

Listen to an audio podcast of the September 1, 2021 FDA Drug Safety Communication on requiring revisions to the Boxed Warning for Xeljanz/Xeljanz XR, Olumiant, and Rinvoq to include information about the risks of serious heart-related events, cancer, blood clots, and death.

مرحبًا بك في مشغل أف ام!

يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.